EOlife receives FDA clearance

April 2023. Archeon has received U.S. Food and Drug Administration (FDA) clearance for its EOlife, the first smart device that measures the quality of manual ventilation. This approval marks a significant milestone for Archeon on its mission to promulgate the practice of high-performance ventilation.